•
Mar 31, 2019

Corcept Therapeutics Q1 2019 Earnings Report

Total Revenue
$64.8M
Previous year: $57.7M
+12.4%
EPS
$0.2
Previous year: $0.19
+5.3%
R&D Expenses
$20.2M
SG&A Expenses
$24.4M
Gross Profit
$63.6M
Previous year: $56.5M
+12.6%
Cash and Equivalents
$49.7M
Previous year: $33.1M
+49.9%
Free Cash Flow
$23.4M
Previous year: $34.4M
-31.8%
Total Assets
$320M
Previous year: $243M
+31.8%

Corcept Therapeutics

Corcept Therapeutics